LPCN Report

Lipocine Inc.
Stock Exchange: NASDAQ
Sector: healthcare
1.53
Last session price
1.53
Price now
Currency: USD
Reporting currency: USD
ISIN: US53630X1046
INN:
.

LPCN financial statements

* Numbers in thousands
Year
2013 2014 2015 2016 2017 2018 2019 2020 TTM
Capitalization *
66 268 70 853 149 226 65 182 27 271 34 467 11 738 98 568 85 203
EV *
21 004 43 187 129 218 59 621 24 060 36 649 9 157 84 941 84 941
Stock price $
9 5.55 9.06 3.57 1.36 1.6142 0.4535 1.77 1.53
Number of shares *
7 363 12 766 16 471 18 258 20 052 21 352 25 882 55 688 55 688
EPS
-1,44 -1,60 -1,11 -1,04 -1,05 -0,55 -0,50 -0,38 -0,38
Revenue *
0 0 0 0 0 428 165 0 0
Net income *
-10 590 -20 373 -18 208 -18 972 -20 983 -11 660 -13 007 -20 965 -20 965
Operating profit *
-8 759 -20 481 -18 382 -18 458 -21 218 -11 326 -12 900 -17 996 -17 996
Total liabilities *
1 284 1 634 3 392 1 326 6 345 11 418 13 370 10 011 10 011
Net debt *
-45 264 -27 666 -20 008 -5 561 -3 211 2 182 -2 581 -13 627 -13 627
Total assets *
46 108 27 994 45 377 27 343 25 325 20 852 19 658 25 353 25 353
Equity *
44 824 26 360 41 985 26 017 18 980 9 434 6 288 15 342 15 342
Cash and investments *
45 264 27 666 44 383 26 840 21 468 15 251 14 069 19 667 19 667

Over the past 10 years, the maximum capitalization of Lipocine Inc. is 149 226, the minimum is 11 738.
Maximum net income 0, Minimum net income -20 983.
The maximum price of LPCN shares is 9.06, the minimum price is 0.4535.

.

LPCN valuation

Year
2013 2014 2015 2016 2017 2018 2019 2020 TTM
P/E
-6,26 -3,48 -8,20 -3,44 -1,30 -2,96 -0,90 -4,70 -4,06
P/B
1,48 2,69 3,55 2,51 1,44 3,65 1,87 6,42 5,55
P/S
0,00 0,00 0,00 0,00 0,00 80,52 71,14 2 593 890 000,00 2 242 180 000,00
E/P
-16% -29% -12% -29% -77% -34% -111% -21% -25%
P/FCF
-7,71 -4,08 -9,70 -3,55 -1,63 -2,85 -1,01 -6,44 -5,57
.

LPCN profitability

Year
2013 2014 2015 2016 2017 2018 2019 2020 TTM
ROE
-24% -77% -43% -73% -111% -124% -207% -137%
ROA
-23% -73% -40% -69% -83% -56% -66% -83%
ROIC
-20% -78% -44% -71% -112% -69% -88% -96%